Cited by 374Cancer Immunotherapy and BiomarkersGenetic factors in colorectal cancerColorectal Cancer Treatments and Studies

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy

Open access

Xiao, Yanping, Freeman, Gordon J.·2015·Cancer Discovery

DOI 10.1158/2159-8290.cd-14-1397PMC PMC4295637

Open this paper in CoChat — free account

Abstract

Summary: The microsatellite instable (MSI) subset of colorectal cancer exhibits an active Th1/CTL immune microenvironment, probably due to recognition of a high number of tumor neoantigens. However, the high expression of checkpoint molecules PD-1, PD-L1, CTLA-4, LAG-3, and IDO in MSI colorectal cancer distinguishes MSI from microsatellite stable colorectal cancer and creates an immunosuppressive microenvironment that may help MSI tumors evade immune destruction by the infiltrating immune cells. Though colorectal cancer does not have a good response rate to PD-1 pathway immunotherapy, these results suggest that the MSI subset of colorectal cancer is a particularly good candidate for checkpoint immunotherapy. Cancer Discov; 5(1); 16–8. ©2015 AACR. See related article by Llosa et al., p. 43

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-14-1397

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Taube, J. M., Anders, R. A., Young, G. D., Xu, H., Sharma, R., McMiller, T. L., Chen, S., Klein, A. P., Pardoll, D. M., Topalian, S. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003689 · Cited by 2,157
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
Self-citation
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
Landon, M., Saam, J. R., Brown, K. L., Moyes, K., Evans, B. A., & WENSTRUP, R. J. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,943
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M. F., Giovannucci, E. L., & Fuchs, C. S. (2008) · Gut · doi:10.1136/gut.2008.155473 · Cited by 772
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Smyrk, T. C., Watson, P. A., Kaul, K. L., & Lynch, H. T. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12 · Cited by 522
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
Prendergast, G. C., Smith, C., Thomas, S., Mandik‐Nayak, L., Laury‐Kleintop, L. D., Metz, R. A., & Muller, A. J. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1549-4 · Cited by 491
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.-O., Sugai, T., An, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1865 · Cited by 465
Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
Lochhead, P. J., Kuchiba, A., Imamura, Y., Liao, X., Yamauchi, M., Nishihara, R., Qian, Z. R., Morikawa, T., Shen, J., Meyerhardt, J. A., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt173 · Cited by 442

Show all 11 references

Sorted by citations

Items 201–300 of 374

Expression status of four mismatch repair proteins in patients with colorectal cancer: clinical significance in 1238 cases.
Chen, L., Chen, G., Zheng, X., & Chen, Y. (2019) · Europe PMC (PubMed Central) · Cited by 16
Clinicopathological features and prognostic value of mismatch repair protein deficiency in gastric cancer.
Zhang, Q., Wang, L., Ni, S., Tan, C., Cai, X., Huang, D., & Sheng, W. (2018) · Europe PMC (PubMed Central) · Cited by 16
Inflammatory immune infiltration in human tumors: Role in pathogenesis and prognostic and diagnostic value
Васильевна, Б. А., & Belousov, P. V. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916110043 · Cited by 15
Beyond precision surgery: Molecularly motivated precision care for gastric cancer
Choi, Y. Y., & Cheong, J. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.02.013 · Cited by 15
Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma
Adashek, J. J., Salgia, M. M., Posadas, E. M., Figlin, R. A., & Gong, J. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.01.004 · Cited by 15
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer
Park, S., Lee, E., Park, S., Lee, S., Nam, S. J., Kim, S. W., Lee, J. E., Yu, J., Kim, J., Ahn, J. S., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1108 · Cited by 14
IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma
Shao, Y., Ni, J.-J., Wei, S., Weng, X., Shen, M., Jia, Y., & Meng, L.-N. (2020) · Medicine · doi:10.1097/md.0000000000022170 · Cited by 15
Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4+ T Cells in the Central Region of pMMR CRC
Qi, J., Liu, X., Yan, P., He, S., Lin, Y., Huang, Z., Zhang, S., Xie, S., Li, Y., Lü, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724232 · Cited by 15
Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03431-6 · Cited by 15
Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment
Talaat, I. M., Elemam, N. M., Zaher, S., & Saber-Ayad, M. M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.955599 · Cited by 15
Prospects for a personalized peptide vaccine against lung cancer
Nakahara, Y., Kouro, T., Igarashi, Y., Kawahara, M., & Sasada, T. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1635461 · Cited by 15
Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity
Aoki, T., Nishida, N., & Kudo, M. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211056853 · Cited by 15
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma
Aoki, T., Kudo, M., Ueshima, K., Morita, M., Chishina, H., Takita, M., Hagiwara, S., Ida, H., Minami, Y., Tsurusaki, M., et al. (2023) · Liver Cancer · doi:10.1159/000531024 · Cited by 14
MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection
Cao, Y., Wang, D., Wu, J., Yao, Z., Shen, S., Niu, C., Liu, Y., Zhang, P., Wang, Q., Wang, J., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad362 · Cited by 14
Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment
Jia, M., Yuan, Z., Yu, H., Feng, S., Tan, X., Long, Z., Duan, Y., Zhu, W., & Yan, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116883 · Cited by 14
Application of Cyclodextrin for Cancer Immunotherapy
Wei, X., Yu, C., & Wei, H. (2023) · Molecules · doi:10.3390/molecules28145610 · Cited by 14
Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis
Tang, W., Liu, H., Li, X., Ooi, T. C., Rajab, N. F., Cao, H., & Sharif, R. (2023) · Journal of Oncology · doi:10.1155/2023/2611105 · Cited by 13
Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients
Gkekas, I., Novotný, J., Fabián, P., Němeček, R., Palmqvist, R., Strigård, K., John, S., Pecen, L., Reginacova, K., & Gunnarsson, U. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25798 · Cited by 13
Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome–Associated Lung Adenocarcinoma
Masuzawa, K., Asakura, T., Ikemura, S., Yasuda, H., Kawada, I., Takaoka, S., Hayashi, Y., Nakajima, T., Arai, M., Fukunaga, K., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00156 · Cited by 13
Pan-cancer analysis reveals that neurotrophin signaling correlates positively with anti-tumor immunity, clinical outcomes, and response to targeted therapies and immunotherapies in cancer
Feng, Q., Song, D., Zhou, H., Lu, H., & Wang, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119848 · Cited by 13
Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers
Kim, J. H., Hong, J., Lee, J. A., Jung, M., Choi, E., Cho, N., Kang, G. H., & Kim, S. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03805-3 · Cited by 12
Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective
Liu, N., Shan, F., & Ma, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108017 · Cited by 13
IRnet: Immunotherapy response prediction using pathway knowledge-informed graph neural network
Jiang, Y., Immadi, M. S., Wang, D., Zeng, S., On Chan, Y., Zhou, J., Xu, D., & Joshi, T. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.036 · Cited by 12
Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma
Giacomelli, M., Monti, M., Pezzola, D. C., Lonardi, S., Bugatti, M., Missale, F., Cioncada, R., Melocchi, L., Giustini, V., Villanacci, V., et al. (2023) · Cancers · doi:10.3390/cancers15123097 · Cited by 11
The mutational profile and infiltration pattern of murine MLH1-/- tumors: concurrences, disparities and cell line establishment for functional analysis
Maletzki, C., Beyrich, F., Hühns, M., Klar, E., & Linnebacher, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10677 · Cited by 12
The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer
Chen, Z., Chen, C., Li, L., Zhang, T., & Wang, X. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.09.029 · Cited by 12
Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer
Zhou, D., Tang, E., Wang, W., Xiao, Y., Huang, J., Liu, J., Zheng, C., Zhang, K., Hu, R., Wang, F., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102158 · Cited by 11
Self-citation
Current and future molecular profiling of cancer by next-generation sequencing: Table 1.
Shibata, T. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv122 · Cited by 11
Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in colon cancer
Zhou, L., Zhang, Y., Wei, M., Du, K., Lin, J., & Wei, L. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02896-z · Cited by 11
Differences in gene expression profiling and biomarkers between histological colorectal carcinoma subsets from the serrated pathway
García‐Solano, J., Turpín, M. C., Garcia‐García, F., Carbonell‐Muñoz, R., Torres‐Moreno, D., Conesa, A., & Conesa‐Zamora, P. (2019) · Histopathology · doi:10.1111/his.13889 · Cited by 11
Intratumoral T-cell repertoires in DNA mismatch repair-proficient and -deficient colon tumors containing high or low numbers of tumor-infiltrating lymphocytes
Kim, J. K., Chen, C., Keshinro, A. O., Khan, A., Fırat, C., Vanderbilt, C., Segal, N. H., Stadler, Z. K., Shia, J., Balachandran, V. P., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2054757 · Cited by 11
A systematic analysis of C5ORF46 in gastrointestinal tumors as a potential prognostic and immunological biomarker
Jiang, Y., Wang, X., Li, L., He, J., Jin, Q., Long, D., Liu, C., Zhou, W., & Liu, K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.926943 · Cited by 10
Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications
Stenzinger, A., & Weichert, W. (2017) · Pathobiology · doi:10.1159/000446545 · Cited by 10
Oxaliplatin-Fluoropyrimidine Combination (XELOX) Therapy Does Not Affect Plasma Amino Acid Levels and Plasma Markers of Oxidative Stress in Colorectal Cancer Surgery Patients: A Pilot Study
Aquilani, R., Brugnatelli, S., Dossena, M., Maestri, R., Delfanti, S., Buonocore, D., Boschi, F., Simeti, E., Condino, A. M., & Verri, M. (2019) · Nutrients · doi:10.3390/nu11112667 · Cited by 10
Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line
Pyo, D. H., Hong, H. K., Lee, W. Y., & Cho, Y. B. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1738907 · Cited by 13
Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer
Shaib, W. L., Zakka, K., Jiang, R., Yan, M., Alese, O. B., Akce, M., Wu, C. S.-Y., Behera, M., & El‐Rayes, B. F. (2020) · Cancer · doi:10.1002/cncr.33049 · Cited by 10
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab
Okazaki, S., Loupakis, F., Stintzing, S., Cao, S., Zhang, W., Yang, D., Ning, Y., Sunakawa, Y., Stremitzer, S., Matsusaka, S., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0931 · Cited by 10
N_LyST: a simple and rapid screening test for Lynch syndrome
Susanti, S., Fadhil, W., Ebili, H. O., Asiri, A., Nestarenkaitė, A., Hadjimichael, E., Ham-Karim, H. A., Field, J., Stafford, K., Matharoo‐Ball, B., et al. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205013 · Cited by 10
Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
Fu, Y., Ye, Y., Liu, X., Zhu, G., Xu, Y., Sun, J., Wu, H., Feng, F., Wen, Z., Jiang, S., et al. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2762 · Cited by 9
Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
Yan, L., Li, Y., Xia, Z., Dun, Z., Chen, X., Wang, X., Liao, J., Wei, Y., & Chen, J. (2021) · Aging · doi:10.18632/aging.203771 · Cited by 9
Mutanome and expression of immune response genes in microsatellite stable colon cancer
Pamplona, R. S., Gil-Hoyos, R., López‐Doriga, A., Alonso, M. H., Aussó, S., Mollevı́, D. G., Santos, C., Sanjuán, X., Salazar, R., Alemany, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7293 · Cited by 9
Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
Kim, E., Kim, K., Kim, S. H., Han, S., Kim, T., Jeong, S., Park, K. J., Koh, J., Kang, G. H., & Chie, E. K. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.434 · Cited by 9
Personalized peptide vaccines for cancer therapy: current progress and state of the art
Wada, S., Yada, E., Ohtake, J., & Sasada, T. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1403286 · Cited by 9
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
Herold, Z., Acs, M., Szász, A. M., Olasz, K., Hussong, J., Mayr, M., Dank, M., & Piso, P. (2022) · Cancers · doi:10.3390/cancers14163978 · Cited by 10
Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis
Zhou, J., Guo, H., Liu, L., Feng, M.-L., Yang, X., & Hao, S. (2022) · Aging · doi:10.18632/aging.204302 · Cited by 8
Temozolomide combined with ipilimumab plus nivolumab enhances T cell killing of MGMT-expressing, MSS colorectal cancer cells.
Gonzalez, Z., Carlsen, L., & El‐Deiry, W. S. (2023) · PubMed Central · Cited by 8
Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers
Wang, Y., Vnencak‐Jones, C. L., Cates, J., & Shi, C. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.02.001 · Cited by 8
Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes
Chen, C., Luo, J., & Wang, X. (2022) · Medical Oncology · doi:10.1007/s12032-022-01719-7 · Cited by 9
From targeted therapy to a novel way: Immunogenic cell death in lung cancer
Xu, J., Xiong, Y., Xu, Z., Xing, H., Zhou, L., & Zhang, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1102550 · Cited by 10
Molecular Profiling of Synchronous Colon Cancers and Anaplastic Thyroid Cancer in a Patient with Lynch Syndrome
Johnson, J. M., Chen, J., Ali, S. M., Dardi, I. K., Tuluc, M., Cognetti, D. M., Campling, B. G., & Sama, A. R. (2016) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9878-5 · Cited by 8
SET nuclear proto-oncogene gene expression is associated with microsatellite instability in human colorectal cancer identified by co-expression analysis
Wang, H., Qiu, P., Zhu, S., Zhang, M., Li, Y., Zhang, M., Wang, X., Shang, J., Qu, B., Liu, J., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.07.020 · Cited by 8
Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma
Xu, T., Chai, J., Wang, K., Jia, Q., Liu, Y., Wang, Y., Xu, J., Yu, K., Zhao, D., Ma, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638154 · Cited by 8
Colorectal signet ring cell carcinoma: advancing research in a rare cancer
Barresi, V., & Pedrazzani, C. (2020) · Future Oncology · doi:10.2217/fon-2020-0242 · Cited by 8
Anoikis-related signature identifies tumor microenvironment landscape and predicts prognosis and drug sensitivity in colorectal cancer
Pan, Y.-B., Xu, W., Huang, M., Lu, Y.-D., Zhou, Y., Teng, Y., Gong, J., Fu, X.-Y., Mao, X., & Li, S. (2024) · Journal of Cancer · doi:10.7150/jca.91627 · Cited by 7
Predictive molecular markers in the era of immunotherapy
Nagaria, T. S., Wang, H., & Wang, H. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000043 · Cited by 7
Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
Ágoston, E. I., Ács, B., Herold, Z., Fekete, K., Kulka, J., Nagy, Á., Mühl, D., Mohácsi, R., Dank, M., Garay, T., et al. (2022) · Genes · doi:10.3390/genes13040589 · Cited by 7
The predictive value and correlation of β-catenin, CMTM6, and PD-L1 expression in colorectal cancer
Li, B., Wu, S., Qiu, Z., Zhong, X., Chen, Z., Luo, F., Li, J., & Liu, K. (2022) · Neoplasma · doi:10.4149/neo_2022_210809n1122 · Cited by 7
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
Maiorano, B. A., Parisi, A., Maiello, E., & Ciardiello, D. (2022) · Life · doi:10.3390/life12101552 · Cited by 8
Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer
Bailey, M. M., Morand, S. M., Royfman, R., Lin, L., Singh, A. P., Stanbery, L., Walter, A., Hamouda, D., & Nemunaitis, J. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063173 · Cited by 7
Intratumoral HLA-DR−/CD33+/CD11b+ Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Hasnis, E., Dahan, A., Khoury, W. E., Duek, D., Fisher, Y., Beny, A., Shaked, Y., Chowers, Y., & Half, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01375 · Cited by 7
Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer
Jiang, Z., Zhang, Y., Chen, K., Yang, X., & Liu, J. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s327765 · Cited by 8
The DNA mismatch repair pathway
Martin, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00006-1 · Cited by 7
Is tumor mutational burden predictive of response to immunotherapy?Preprint
Gurjao, C., Tsukrov, D. I., Imakaev, M., Luquette, L. J., & Mirny, L. A. (2023) · doi:10.7554/elife.87465.1 · Cited by 8
Dipeptidase-1–knockout mice develop invasive tumors with features of microsatellite-unstable colorectal cancer
Glass, S. E., Bechard, M. E., Cao, Z., Aramandla, R., Zhao, P., Ellis, S. T., Green, E. H., Fisher, E., Smith, R. T., Sievers, C. K., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.186938 · Cited by 6
Itaconate and obesity-related hormones promote tumor progression – new insights on metabolic dysfunction in early-onset colon cancer
Scheurlen, K. M., Hallion, J. C., Snook, D. L., Macleod, A., Beal, R. J., Parks, M. A., Littlefield, A. B., Hiken, E., Billeter, A. T., Bensen, J. T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1572985 · Cited by 6
Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer
Zhou, Z., Li, K., Wei, Q., Chen, L., Shuai, Y., Wang, Y., He, K., Si, L., Zhong, Y., & Lu, J. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-572 · Cited by 5
Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells
Shechter, S., Bar, S. Y., Khattib, H., Gage, M. J., & Avni, D. (2023) · Molecules · doi:10.3390/molecules28114452 · Cited by 6
Altérations moléculaires au cours de la carcinogenèse urothéliale vésicale
Pignot, G., le Goux, C., & Bièche, I. (2015) · Bulletin du Cancer · doi:10.1016/j.bulcan.2015.10.004 · Cited by 6
miR-181a-2* expression is different amongst carcinomas from the colorectal serrated route
Kondelová, A., Alburquerque-González, B., Vychytilova‐Faltejskova, P., García‐Solano, J., Procházka, V., Kala, Z., Pérez-Sánz, F., Slabý, O., & Conesa‐Zamora, P. (2019) · Mutagenesis · doi:10.1093/mutage/gez039 · Cited by 6
Personalised mapping of tumour development in synchronous colorectal cancer patients
Thomas, V., Cotter, M. B., Tosetto, M., Khaw, Y. L., Geraghty, R., Winter, D. C., Ryan, E. J., Sheahan, K. D., & Furney, S. J. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-0134-3 · Cited by 6
Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice
Nakayama, I., Shinozaki, E., Kawachi, H., Sasaki, T., Yunokawa, M., Tomomatsu, J., Yuasa, T., Kitazono, S., Kobayashi, K., Hayakawa, K., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5569 · Cited by 5
Epidermal growth factor receptor intron 1 polymorphism and microsatellite instability in sporadic colorectal cancer
Marinović, S., Vuković, K., Škrtić, A., Poljak, M., Petek, S., Petek, L., & Kapitanović, S. (2020) · Oncology Letters · doi:10.3892/ol.2020.12392 · Cited by 5
Lynch syndrome: five unanswered questions
Castellsagué, E., & Foulkes, W. D. (2015) · Clinical Genetics · doi:10.1111/cge.12580 · Cited by 5
The immunological nexus between inflammatory bowel disease and colorectal cancer: A molecular perspective
Rachma, B., Pamungkas, R. P., Sandra, D. Y., Sutanto, H., & Fetarayani, D. (2025) · Clinical Immunology Communications · doi:10.1016/j.clicom.2025.11.004 · Cited by 4
Gastric metaplasia could initiate the serrated neoplasia pathway in CRC
IJspeert, J. E. G., & Dekker, E. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00592-z · Cited by 4
Integrative Analysis of Multi-Omics Data-Identified Key Genes With KLRC3 as the Core in a Gene Regulatory Network Related to Immune Phenotypes in Lung Adenocarcinoma
Mao, K., Zhao, Y., Ding, B., Feng, P., Li, Z., Zhou, Y. L., & Xue, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.810193 · Cited by 4
m6A Regulator‐Based Exosomal Gene Methylation Modification Patterns Identify Distinct Microenvironment Characterization and Predict Immunotherapeutic Responses in Colon Cancer
Zheng, J., Feng, P., Chen, D., Zhang, C., Ji, Y., Liu, Y., Fan, X., & Li, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9451480 · Cited by 4
Cell-Based Immunotherapy Approaches for Colorectal Cancer: Main Achievements and Challenges
Shahnazari, M., Samadi, P., Pourjafar, M., & Jalali, A. (2021) · Future Oncology · doi:10.2217/fon-2020-1218 · Cited by 4
Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer
Wang, X., Chen, K., Wang, Z., Xu, Y., Dai, L., Bai, T., Chen, B., Yang, W., & Chen, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.750709 · Cited by 4
APOBEC3B and CD274 as Combined Biomarkers for Predicting Response to Immunotherapy in Urothelial Carcinoma of the Bladder
Zhang, C., Cheng, Z., Wang, Z., Zhao, G., Yuan, Y., & Wang, R. (2022) · Journal of Oncology · doi:10.1155/2022/6042334 · Cited by 4
Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma
Chevalier, B., Karleskind, O., Jannin, A., Farchi, O., Vermaut, C., Escande, A., Baillet, C., Espiard, S., Vantyghem, M., Carnaille, B. M. L., et al. (2022) · European Thyroid Journal · doi:10.1530/etj-22-0111 · Cited by 4
Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients
Arakawa, K., Hata, K., Nozawa, H., Kawai, K., Tanaka, T., Nishikawa, T., Sasaki, K., Shuno, Y., Kaneko, M., Hiyoshi, M., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13258 · Cited by 4
Revealing unidentified heterogeneity in different epithelial cancers using heterocellular subtype classificationPreprint
Poudel, P., Nyamundanda, G., Ragulan, C., Lawlor, R. T., Das, K., Tan, P. B. O., Scarpa, A., & Sadanandam, A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/175505 · Cited by 4
Omega-3 Fatty Acid Supplementation—A Possible Dietary Adjunct to Enhance Immune Therapy in Cancer?Preprint
Wachtel, N., Rohwer, N., Pietzner, A., Loew, A., & Weylandt, K. H. (2018) · Preprints.org · doi:10.20944/preprints201804.0115.v1 · Cited by 4
Rewiring Metal-Dependent Cell Death to Unlock Immunotherapy in Colorectal Cancer
Zhao, R., Wang, X., Wang, J., Liu, H., Zhang, G., Wu, X., Cheng, F., & Wang, L. (2026) · Nano Letters · doi:10.1021/acs.nanolett.6c00449 · Cited by 3
Cancer-associated fibroblasts gene signature: a novel approach to survival prediction and immunotherapy guidance in colon cancer
Zhang, W., Yang, C., Lu, Y., Tang, C., Zhao, M., Wang, Z., Gao, J., Hu, S., & Chen, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1532306 · Cited by 3
Peripheral Blood T‐Cell Receptor Repertoire Diversity as a Potential Biomarker in the Diagnosis and Treatment Evaluation of Colorectal and Lung Cancers: A Prospective Observational Study
Ma, J., Wang, Y., Zhang, Z., Cai, X., Xiang, X., Chen, Y., Sun, F., & Dong, J. (2025) · Cancer Medicine · doi:10.1002/cam4.70937 · Cited by 3
A mutational signature for colorectal cancer prognosis prediction: Associated with immune cell infiltration
Xu, L., Lin, Y., Chen, X., Zheng, L., Cheng, Y., Hu, J., Zheng, B., Zhang, B., Li, G., Chi, Z., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.414 · Cited by 3
Modeling combination chemo‐immunotherapy for heterogeneous tumors
Chen, S., Hu, Z., & Zhou, D. (2025) · Quantitative Biology · doi:10.1002/qub2.98 · Cited by 3
[Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC].
Lan, Q., Ji, C., & Yao, Y. (2019) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2019.08.06 · Cited by 3
The interface of malignant and immunologic clonal dynamics in high-grade serous ovarian cancerPreprint
Zhang, A. W., McPherson, A., Milne, K., Kroeger, D. R., Hamilton, P. T., Miranda, A., Funnell, T., Laan, S., Cochrane, D. R., Lim, J. L., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/198101 · Cited by 3
A deep profile of gene expression across 18 human cancersPreprint
Qiu, W., Dincer, A. B., Janizek, J. D., Çelik, S., Pittet, M. J., Naxerova, K., & Lee, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.17.585426 · Cited by 3
Prognostic and predictive value of microsatellite instability status among patients with colorectal cancer
Baidoun, F., Saad, A. M., & Abdel-Rahman, O. M. (2021) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2021-0013 · Cited by 2
Integrative learning in developing an immunologic lncRNA signature as a consensus risk-stratification tool for lung adenocarcinoma
Chen, Z., Liu, Y., Wan, C., & Huang, W. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-372 · Cited by 1
Host genetics-associated mechanisms in colorectal cancer
González, A., Fullaondo, A., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.003 · Cited by 2
Association between liver targeted antiviral therapy in colorectal cancer and survival benefits: An appraisal
Wang, Q., & Yu, C. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i11.2111 · Cited by 2
Immune Checkpoint Blockade and Gastric Cancer
Su, S., & Liu, B. (2017) · Springer eBooks · doi:10.1007/978-981-10-3978-2_9 · Cited by 2
Role of the Microbiome in the Formation and Development of Colorectal Cancer
Zwinsova, B., Brychtová, V., Hrivňáková, M., Dubská, L. Z., Bencsiková, B., Nenutil, R., Vídeňská, P., & Budínská, E. (2019) · Klinicka onkologie · doi:10.14735/amko2019261 · Cited by 3
Synchronous Recto-Sigmoid Colorectal Carcinomas With Microsatellite Instability and an Activating PIK3CA Mutation
Mathavan, M., Mathavan, A., Mathavan, A., & Altshuler, E. (2022) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096221121406 · Cited by 2
Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report
Николаевна, Б. Н., Popova, N. O., Grigoryev, Е. G., Дронова, Т. А., Анатольевна, Г. П., Dobrodeev, А. Y., Костромицкий, Д. Н., Goldberg, V. E., Afanasiev, S. G., & Чердынцева, Н. В. (2024) · Drug Target Insights · doi:10.33393/dti.2024.2637 · Cited by 2

Authors: Xiao, Y., & Freeman, G. J.
Affiliations: Harvard University (US)
Corresponding author: Freeman, Gordon J.
ORCID: Freeman, Gordon J.
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2015-01-01
Volume: 5
Issue: 1
Pages: 16-18
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-14-1397
PMC: PMC4295637
OpenAlex: W2042797183
Cited by: 368
References: 11
Citations by year: 2026: 5 · 2025: 13 · 2024: 17 · 2023: 26 · 2022: 54 · 2021: 44 · 2020: 36 · 2019: 46 · 2018: 35 · 2017: 40 · 2016: 37 · 2015: 14
FWCI: 18.34
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Discovery (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Public Health Service (HHSN272201100018C)
National Cancer Institute (U54CA163125, P50CA101942)
National Institute of Allergy and Infectious Diseases (HHSN272201100018C, P01AI056299)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords: microsatellite instability, colorectal cancer, immune checkpoint blockade, PD-1, PD-L1, CTLA-4, LAG-3, IDO, tumor immune microenvironment, neoantigens, immunosuppression, immunotherapy response
MeSH terms: Colonic Neoplasms, Humans, Microsatellite Instability, Tumor Microenvironment, Cell Cycle Checkpoints

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks